Preserve study integrity. Resist the temptation to bolt new exploratory endpoints midstream. If an additional endpoint is ...

Chief among its criticisms is Novavax's failure to build sales of its protein-based COVID-19 vaccine Nuvaxovid/Covovax, a ...

France-based investment group Jeito Capital has closed its second fund, raking in €1 billion ($1.2 billion), which it claims ...

LC: Manufacturability is the field's most critical near-term challenge, especially for ex vivo cell therapies. Encouragingly, ...

A legal bid to introduce a temporary block on remote access to the abortion pill mifepristone in the US, while the Trump ...

Baldo discusses the ocular disease landscape, as well as Beacon’s work targeting X-linked retinitis pigmentosa (XLRP) and ...

In modern drug discovery, successfully navigating the progress from molecular concept to viable therapeutic often hinges on ...

The FDA has approved orforglipron, under the Foundayo trade name, in just 50 days, thanks to a fast track review under the ...

Radiopharmaceuticals are rapidly becoming one of the most dynamic areas of oncology drug development. By combining molecular targeting with controlled radiation delivery, these therapies introduce a ...

Gilead Sciences has signed its third acquisition deal since the start of the year, agreeing to buy Germany's Tubulis and its pipeline of antibody-drug conjugates (ADCs) for cancer. Assuming the ...

The prize for Neurocrine is Soleno's Vykat XR (diazoxide choline) medicine for Prader-Willi syndrome (PWS), which was ...

HHS Secretary Robert F Kennedy Jr has followed a court ruling that his controversial appointments to the CDC's Advisory Committee on Immunization Practices (ACIP) were unlawful by changing the panel's ...